Iomai to Present at BIO CEO & Investor Conference
Last update: 2/9/2007 8:30:00 AM
GAITHERSBURG, Md., Feb 09, 2007 /PRNewswire-FirstCall via COMTEX/ -- Iomai Corporation (IOMI) today announced that Stanley C. Erck, the company's president and chief executive officer, will speak at the 9th Annual BIO CEO & Investor Conference on Tuesday, February 13 at 9:45 a.m. Eastern Time. In addition, Mr. Erck will take part in a panel discussion, "The Pandemic Panic," taking place Monday, February 12 at 9:30 a.m.
In his presentation, Erck will give an overview of the $128 million government contract for the study of a dose-sparing patch for use with a pandemic influenza vaccine, awarded to Iomai last month, as well as details on the company's three clinical patch-based vaccine programs.
The conference is being held at the Waldorf-Astoria Hotel in New York.
Iomai last month announced that it would receive a contract from the Department of Health and Human Services (DHHS) to fund the company's development of a dose-sparing patch for use with a pandemic influenza vaccine. If the product is developed through licensure, the total cost reimbursed by DHHS, plus the fixed fee, is estimated to be $128 million.
To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at . Please connect to Iomai's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.
